Resilience and its correlates in patients with narcolepsy type 1.
adaptation
anxiety
cataplexy
depression
narcolepsy
quality of life
resilience
sleepiness
Journal
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977
Informations de publication
Date de publication:
01 04 2023
01 04 2023
Historique:
pmc-release:
01
04
2024
medline:
5
4
2023
pubmed:
24
1
2023
entrez:
23
1
2023
Statut:
ppublish
Résumé
This study aimed to explore resilience and its possible association with sociodemographic and clinical features in patients with narcolepsy type 1 (NT1). This was a cross-sectional study involving patients with NT1 and age-/sex-matched controls (comparison group). Sociodemographic and clinical data were collected through semistructured interviews and validated questionnaires, including the Epworth Sleepiness Scale (ESS), State-Trait Anxiety Inventory (STAI)-State Anxiety, Beck Depression Inventory (BDI), 36-item Short Form Survey (SF-36), and the Resilience Scale (RS). Different statistical approaches were used to investigate the relationship between resilience and NT1 and associations with sociodemographic and clinical features. The participants comprised 137 patients (mean age, 38.0 years; 52.6% female) and 149 controls (39.6 years; 55.7% female). Compared with controls, patients had a significantly lower (122.6 vs 135.5) mean RS score and a 2-fold risk of having low/mild-range resilience (adjusted odds ratio = 1.99, 95% confidence interval 1.13-3.52). Patients with high resilience had sociodemographic and narcolepsy characteristics similar to patients with low resilience, but they reported anxiety and depressive symptomatology less frequently (4.2% vs 55.8% and 58.3%, respectively), and their SF-36 scores were comparable to those of the comparison group. In patients, RS score was strongly associated with STAI-State Anxiety and BDI (rho = -0.57 and -0.56, respectively) and weakly with ESS (rho = -20) scores. The results of this study suggest that resilience may play a key role in patients' adaptation to NT1. Furthermore, this study supports interventions aimed at increasing patients' resilience and provides a base for further studies, preferably longitudinal and including objective measures, directed toward understanding the relationship between resilience, depression, and quality of life in patients with narcolepsy. D'Alterio A, Menchetti M, Zenesini C, et al. Resilience and its correlates in patients with narcolepsy type 1.
Identifiants
pubmed: 36689313
pii: jcsm.10418
doi: 10.5664/jcsm.10418
pmc: PMC10071382
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
719-726Informations de copyright
© 2023 American Academy of Sleep Medicine.
Références
Sleep. 2016 Jul 01;39(7):1389-98
pubmed: 27166243
Sleep Med. 2020 Jan;65:96-104
pubmed: 31739232
Behav Sleep Med. 2022 Mar-Apr;20(2):260-268
pubmed: 33877929
BMJ Open. 2018 Jun 14;8(6):e017858
pubmed: 29903782
Nat Rev Neurol. 2019 Sep;15(9):519-539
pubmed: 31324898
J Sleep Res. 2021 Dec;30(6):e13387
pubmed: 34173288
Brain Res. 2020 Mar 15;1731:146085
pubmed: 30590027
Rehabil Psychol. 2018 Feb;63(1):29-42
pubmed: 29154558
J Clin Sleep Med. 2021 Sep 1;17(9):1895-1945
pubmed: 34743790
Biol Psychiatry. 2022 May 1;91(9):841-852
pubmed: 35279280
PLoS One. 2015 Apr 21;10(4):e0122478
pubmed: 25898361
Neuropharmacology. 2018 Dec;143:79-94
pubmed: 30240784
Health Soc Care Community. 2019 Jul;27(4):797-807
pubmed: 30027595
Sleep Med. 2014 May;15(5):502-7
pubmed: 24780133
Pediatr Neurol. 2018 Aug;85:21-32
pubmed: 30190179
Mult Scler Relat Disord. 2018 Oct;25:309-315
pubmed: 30176401
Rheumatol Int. 2021 Nov;41(11):1987-1994
pubmed: 34091740
Clin Exp Rheumatol. 2010 Sep-Oct;28(5):669-78
pubmed: 20822709
Sleep Med. 2011 Jan;12(1):19-23
pubmed: 20851047
Mol Psychiatry. 2019 Feb;24(2):282-293
pubmed: 30087452
Neuropsychol Rev. 2021 Mar;31(1):89-102
pubmed: 32671534
Sleep Med. 2021 Jun;82:193-199
pubmed: 33957415
Neurotherapeutics. 2017 Jul;14(3):677-686
pubmed: 28397115
Arch Clin Neuropsychol. 2021 Feb 12;36(2):283-306
pubmed: 31768521
J Clin Sleep Med. 2017 Aug 15;13(8):1017-1018
pubmed: 28728625
Nat Rev Neurosci. 2019 Feb;20(2):83-93
pubmed: 30546103
Front Neuroendocrinol. 2018 Oct;51:132-145
pubmed: 29932958
Eur J Neurosci. 2021 Jan;53(1):183-221
pubmed: 31421056
eNeuro. 2018 Apr 16;5(2):
pubmed: 29662948
J Clin Sleep Med. 2022 Jul 1;18(7):1769-1778
pubmed: 35332869
J Sleep Res. 2021 Dec;30(6):e13383
pubmed: 34036640
Sleep Med. 2014 May;15(5):522-9
pubmed: 24768358
Sleep Med. 2012 Dec;13(10):1293-300
pubmed: 23026503
Epilepsy Behav. 2020 Feb;103(Pt A):106398
pubmed: 31668786
Rehabil Psychol. 2018 Aug;63(3):338-348
pubmed: 30024203
Neurotherapeutics. 2021 Jan;18(1):6-19
pubmed: 33886090
Chronobiol Int. 2017;34(6):677-686
pubmed: 28448731
Seizure. 2011 Jul;20(6):462-7
pubmed: 21414811
Mult Scler Relat Disord. 2022 Jan;57:103360
pubmed: 35158431
Am J Psychiatry. 2004 Feb;161(2):195-216
pubmed: 14754765
J Nurs Meas. 1993 Winter;1(2):165-78
pubmed: 7850498
Sleep Med. 2021 May;81:268-284
pubmed: 33740593
J Clin Sleep Med. 2017 Mar 15;13(3):419-425
pubmed: 27923434
Sleep. 2013 Feb 01;36(2):175-81
pubmed: 23372264
BMC Neurol. 2020 May 11;20(1):176
pubmed: 32393279
Sleep Med. 2004 Sep;5(5):467-75
pubmed: 15341892
Curr Psychiatry Rep. 2016 Jan;18(1):7
pubmed: 26733323
J Sleep Res. 2001 Mar;10(1):75-81
pubmed: 11285058
Pediatr Nephrol. 2015 Dec;30(12):2153-62
pubmed: 26210984
Curr Psychiatry Rep. 2020 Jun 5;22(8):36
pubmed: 32514698
Neurol Sci. 2019 Mar;40(3):447-456
pubmed: 30539345